Apollomics, Inc. (NASDAQ:APLMW – Get Free Report) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 43,253 shares, a growth of 64.2% from the July 15th total of 26,338 shares. Based on an average daily volume of 32,613 shares, the days-to-cover ratio is currently 1.3 days.
Apollomics Stock Down 5.0%
Apollomics stock opened at $0.02 on Tuesday. Apollomics has a 12 month low of $0.00 and a 12 month high of $0.23. The company has a fifty day moving average price of $0.02 and a two-hundred day moving average price of $0.01.
Apollomics Company Profile
Apollomics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and potential commercialization of novel oncology therapies. Since its founding, the company has concentrated on creating targeted and immuno-oncology candidates designed to address unmet needs in solid tumors. Apollomics maintains headquarters in the United States with key research operations in China, leveraging a dual-site strategy to accelerate global development timelines.
The company’s pipeline encompasses a range of therapeutic modalities, including monoclonal antibodies, antibody-drug conjugates and bispecific constructs.
Further Reading
- Five stocks we like better than Apollomics
- Uncle Sam’s Chip Trick: How the Government Built a Silicon Moat
- 3 Infrastructure Stocks Built Around the Backbone of the Economy
- Moonshot to Money: Intuitive Machines Lands $600M Defense Win
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
Receive News & Ratings for Apollomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollomics and related companies with MarketBeat.com's FREE daily email newsletter.
